ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period

S. Sarwar, S. Gleeson, M. Malinis, M. M. Azar

Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT

Meeting: 2019 American Transplant Congress

Abstract number: A358

Keywords: Bacterial infection, Screening

Session Information

Session Name: Poster Session A: Transplant Infectious Diseases

Session Type: Poster Session

Date: Saturday, June 1, 2019

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

*Purpose: Antibiotic prophylaxis for enteric pathogens is recommended before liver transplantation (LT). Perioperative screening protocols and antimicrobials vary between institutions. Some institutions that do not routinely provide perioperative prophylaxis for vancomycin-resistant Enterococcus (VRE) have reported high rates of post-LT VRE infection. Our institution routinely screens for VRE colonization before LT. Colonized individuals receive daptomycin perioperative prophylaxis (DPP) in addition to standard prophylaxis. We sought to determine the incidence and outcomes of VRE infections in VRE-colonized patients within 90 days of LT at our institution.

*Methods: We performed a retrospective chart review of LT recipients aged ≥ 18 years between 2013-2017 to identify VRE-colonized (determined via peri-rectal swab culture) LT recipients and whether they received DPP. We collected demographic and clinical characteristics, particularly risk factors for VRE infection including: type of surgical anastomosis, post-operative hemorrhage, re-operation, dialysis, and prolonged intensive care unit stay. Infections were defined by CDC criteria. Outcomes measured included VRE-related infection and mortality within 90 days of LT.

*Results: There were 18 VRE-colonized patients who received DPP. The median MELD score at the time of transplant was 37 [12-44]. The median Charlson Comorbidity Index score was 6 [3-9]. Seventeen of 18 patients (94.4%) were primary LT. All but 2 patients received basiliximab induction therapy. The majority (88.9%) underwent duct-to-duct biliary reconstruction. One (5.6%) developed biliary leak, and 6 (33.3%) required re-operation within 90 days of LT. Thirteen patients (72.2%) required postoperative dialysis. The median ICU length of stay was 8 days [2-67] post-LT. None developed VRE infection and 1 (5.6%) had asymptomatic VRE bacteriuria. One VRE-colonized LT recipient who did not receive DPP developed post-operative hemorrhage requiring re-operation, VRE bacteremia, and died within 90 days of LT.

*Conclusions: At our institution, known VRE-colonized individuals who underwent LT and received DPP did not develop VRE-related infections in the early post-LT period despite having significant risk factors for VRE infection. Our experience illustrates the importance of pre-LT VRE screening and appropriate prophylaxis in reducing VRE infections in the early post-transplant period.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sarwar S, Gleeson S, Malinis M, Azar MM. Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/daptomycin-perioperative-prophylaxis-for-prevention-of-vancomycin-resistant-enterococcus-infection-in-vre-colonized-liver-transplant-recipients-during-the-early-post-transplant-period/. Accessed May 9, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences